Cite
Condliffe R, Pickworth JA, Hopkinson K, et al. Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension. Pulm Circ. 2012;2(1):21-7doi: 10.4103/2045-8932.94819.
Condliffe, R., Pickworth, J. A., Hopkinson, K., Walker, S. J., Hameed, A. G., Suntharaligam, J., Soon, E., Treacy, C., Pepke-Zaba, J., Francis, S. E., Crossman, D. C., Newman, C. M., Elliot, C. A., Morton, A. C., Morrell, N. W., Kiely, D. G., & Lawrie, A. (2012). Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension. Pulmonary circulation, 2(1), 21-7. https://doi.org/10.4103/2045-8932.94819
Condliffe, Robin, et al. "Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension." Pulmonary circulation vol. 2,1 (2012): 21-7. doi: https://doi.org/10.4103/2045-8932.94819
Condliffe R, Pickworth JA, Hopkinson K, Walker SJ, Hameed AG, Suntharaligam J, Soon E, Treacy C, Pepke-Zaba J, Francis SE, Crossman DC, Newman CM, Elliot CA, Morton AC, Morrell NW, Kiely DG, Lawrie A. Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension. Pulm Circ. 2012 Jan-Mar;2(1):21-7. doi: 10.4103/2045-8932.94819. PMID: 22558516; PMCID: PMC3342744.
Copy
Download .nbib